Showing 34,862 results

Filters
Sex workers

HIV stigma drives sex work in Northern Kenya

Editor's pick
Key Correspondents
27 February 2015
PrEP

UNAIDS welcomes further evidence of the efficacy of antiretroviral medicines in preventing new HIV infections

Editor's pick
UNAIDS
27 February 2015
Starting treatment

Inflammation Persists Despite Very Early HIV Treatment

Editor's pick
The Body Pro
27 February 2015
HIV treatment

Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation

News
27 February 2015
Pharmaceutical industry

Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Editor's pick
Chicago Tribune
27 February 2015
HIV prevention policy

HIV Prevention Cuts Medical Costs

Editor's pick
MedPage Today HIV/AIDS
27 February 2015
Undetectable viral load & treatment as prevention

Treatment cascades and viral load surveys show how African countries can maximise prevention benefits of HIV treatment

News
27 February 2015
Circumcision

Circumcision is reducing HIV incidence in Uganda, Rakai community study shows

News
27 February 2015
Undetectable viral load & treatment as prevention

No HIV transmissions from HIV-positive partner seen in Australian gay couples study

News
27 February 2015
Behaviour change interventions

US PEPFAR abstinence and faithfulness funding had no impact on sexual behaviour in Africa

News
26 February 2015
PrEP

HIV pill: The logic of paying £500 a month so gay men don't have to wear condoms

Editor's pick
The Independent
26 February 2015
TB treatment

CROI 2015: Trial to evaluate the use of health navigators to link HIV/TB patients to care and treatment fails to show positive results

Editor's pick
Science Speaks
26 February 2015
Hepatitis C treatment

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Editor's pick
NICE press release
26 February 2015
New & experimental hepatitis C treatment

New hepatitis C treatments highly effective for HIV/HCV coinfected people

Editor's pick
HIVandHepatitis.com
26 February 2015
New & experimental HIV treatments

48-week analysis of investigational HIV-1 attachment inhibitor paves way for Phase III trial initiation

Editor's pick
Bristol Myers Squibb press release
26 February 2015
Hepatitis C transmission & prevention

Sexual Transmission of HCV in Gay Men Should Not Be a PrEP Deterrent, Say Advocates

Editor's pick
The Body
26 February 2015
Behaviour change interventions

What We Know About HIV Transmission Should Influence PrEP Messaging

Editor's pick
The Body
26 February 2015
Harm reduction

Auto-Disable Syringes Are Not For Needle Programmes

Editor's pick
National Needle Exchange Forum
26 February 2015
PrEP

HIV treatment finally has a game-changer, and it’s called Truvada

Editor's pick
The Guardian
26 February 2015
New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 looks promising in early study

News
26 February 2015
Starting treatment

Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows

News
26 February 2015
Undetectable viral load & treatment as prevention

Combining PrEP and ART could almost eliminate HIV infection, east African study finds

News
26 February 2015
Drug-resistant TB

XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment

News
26 February 2015
Opportunistic infections

Stopping cotrimoxazole during antiretroviral therapy raises risk of bacterial illness, malaria, Ugandan trial shows

News
26 February 2015